The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis

M. Brodlie, M. McKean, G. Johnson, A. Fisher, P. Corris, C. Ward, J. Lordan (Newcastle upon Tyne, United Kingdom)

Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Session: Cystic fibrosis: understanding a complex disease
Session type: E-Communication Session
Number: 464

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Brodlie, M. McKean, G. Johnson, A. Fisher, P. Corris, C. Ward, J. Lordan (Newcastle upon Tyne, United Kingdom). The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis. Eur Respir J 2009; 34: Suppl. 53, 464

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005

Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease
Source: Eur Respir J 2011; 37: 1378-1385
Year: 2011



Characterization of cystic fibrosis airway epithelium in vitro
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Circulating inflammatory cytokines in adult cystic fibrosis patients
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009

Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002



Pro-inflammatory cytokines in cystic fibrosis lungs
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005

Arginase in patients with cystic fibrosis airway disease
Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems
Year: 2004


α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007



Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis
Source: Eur Respir J 2009; 34: 655
Year: 2009



Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis
Source: Eur Respir J 2012; 39: 297-304
Year: 2012



The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013

Ivacaftor decreases monocyte sensitivity to interferon-? in people with cystic fibrosis
Source: ERJ Open Res, 6 (2) 00318-2019; 10.1183/23120541.00318-2019
Year: 2020



Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004

Anti-inflammatory cytokines in cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: 581-587
Year: 2006



Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014


Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction
Source: Eur Respir J 2004; 23: 846-850
Year: 2004